Response to Dr. Mahan Regarding Key Points to Consider When Evaluating Andexxa for Formulary Addition.

Authors

Harry Peled, St Jude Medical Center, Fullerton, CAFollow
Nhu Quyen Dau
Helen Lau, Southern California Regional Clinical Quality and Risk Manager, Providence St. Joseph Health, Irvine, CA, USAFollow

Document Type

Article

Publication Date

6-3-2020

Publication Title

Neurocrit Care

Department

Pharmacy

Recommended Citation

Peled, Harry; Dau, Nhu Quyen; and Lau, Helen, "Response to Dr. Mahan Regarding Key Points to Consider When Evaluating Andexxa for Formulary Addition." (2020). Articles, Abstracts, and Reports. 3254.
https://digitalcommons.providence.org/publications/3254